Who Paid My Doc
Total30
Device Ophthalmology
General payments
$6,636,412
Research payments
$3,003,465
Through program year 2025, $6,636,412 in general payments and $3,003,465 in research payments were reported against Total30 (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,265,409 | 4,213 |
| 2025 | Research | $557,263 | 120 |
| 2024 | General | $1,851,305 | 21,382 |
| 2024 | Research | $741,894 | 357 |
| 2023 | General | $1,622,831 | 25,787 |
| 2023 | Research | $249,710 | 90 |
| 2022 | General | $1,095,562 | 14,065 |
| 2022 | Research | $1,454,598 | 1,641 |
| 2021 | General | $801,305 | 6,479 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
71,926 general · 2,208 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.